Gilead's Letairis Gets Boost Against Actelion's Tracleer With Removal Of Liver Warning

REMS helps drive the endothelin receptor antagonist to a cleaner label, as the pulmonary arterial hypertension drug's black box will be modified and liver testing requirements dropped.